Joshua F. Kriger

Joshua F. Kriger has a diverse work experience in various roles and industries.

Joshua F. started their career as the Founder and Chief of Product Development at eRSVP Inc in 2004, where they were responsible for developing and leading the product development team.

In 2008, they joined Aquilonis as a Partner, Director of United States Operations, and Vice President of Sales and Marketing. At Aquilonis, they focused on building world-class products and innovative solutions for the global Mobile Computing market.

In 2014, Kriger moved on to Baylor University Medical Center as a Lead Statistician. Joshua F.'swork involved designing and conducting clinical trials related to treatments for specific disorders. Joshua F. specifically worked on a study related to the treatment of Mitochondrial Encephalomyopathy, Lactic Acidosis, and Stroke-like episodes (MELAS) using citrulline supplementation.

The same year, they also started working at Columbia University Medical Center as a Statistical Program Manager. In this role, they oversaw the statistical analyses and results presented to Novartis and the RELAX-AHF clinical trial Executive Committee. Joshua F. also managed biostatistic functions to support and manage Statistical Analysis Center (SAC) personnel.

In 2015, Kriger took on the role of Program Manager for the PHIA Project at Columbia University Medical Center - ICAP. Joshua F. was responsible for overseeing and managing statistical analyses, staffing, and milestones for the PHIA project. Joshua F. also developed and maintained systems and standardized processes for tracking and reporting ICAP usages, projects, and outcomes.

Joshua F.'smost recent work experience is as the Chief Executive Officer at Picket Pharmaceuticals since 2018. As the CEO, they are responsible for leading the company and driving its growth and success.

Joshua F. Kriger obtained their Bachelor of Arts (B.A.) degree in Entrepreneurship and Statistics from Hampshire College, graduating in 2007. Following this, they pursued a degree in Biostatistics - Theory and Methods at Columbia University from 2012 to 2014. Joshua then furthered their education at Columbia University, where they obtained an Executive Master's of Health Administration (MHA) degree specializing in Health/Health Care Administration/Management from 2016 to 2018.